Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Consumer Staples
  • Industry: Consumer Products
  • Sub-Industry: Household Products

Soiken Holdings Inc

+ Add to Watchlist

2385:JP

230.0 JPY 0.00.00%

As of 02:00:00 ET on 04/17/2015.

Snapshot for Soiken Holdings Inc (2385)

Open: 230.0 Day's Range: 228.0 - 231.0 Volume: 60,400
Previous Close: 230.0 52wk Range: 197.0 - 450.0 1-Yr Rtn: +0.44%

Stock Chart for 2385

No chart data available.
  • 2385:JP 230.0
  • 1D
  • 1M
  • 1Y
230.0
Interactive 2385 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 2385

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) -
Relative P/E vs. TPX -
Earnings Per Share (JPY) (ttm) -4.1200
Est. EPS (JPY) (06/2015) 1.5000
Est. PEG Ratio -
Market Cap (M JPY) 6,037.50
Shares Outstanding (M) 26.25
30 Day Average Volume 214,583
Price/Book (mrq) 1.5150
Price/Sale (ttm) 2.4456
Dividend Indicated Gross Yield -%
Cash Dividend (JPY) -
Dividend Ex-Date 06/28/2010
5 Year Dividend Growth -
Next Earnings Announcement 05/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 2385

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 2385

Soiken Holdings Inc. develops a variety of biomarkers that are based on research done by university laboratories. The Company also conducts clinical testing for pharmaceutical and food manufacturers that develop drugs and health food products based on biomarkers.

Shinya KoikePresidentOsamu TanabeDirector
Tomohiro SuginoDirector
More Company Profile & Key Executives for 2385

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil